Pharmacotherapy of psychiatric inpatients with mental and behavioral disorders caused by sedatives or hypnotics (F13): Results from an observational pharmacovigilance program between 2000 and 2017

Abstract Background The treatment of choice for substance use disorder (SUD) caused by sedatives, hypnotics, and anxiolytics (SHA) is to slowly taper the dose of the implicated substance to the point of abstinence, thereby minimizing withdrawal symptoms. Concomitant pharmacotherapy may be indicated...

Полное описание

Библиографические подробности

Главные авторы:	Philipp Pauwels, Beatrice Haack, Sermin Toto, Johanna Seifert, Renate Grohmann, Martin Heinze, Oliver Zolk, Phileas Johannes Proskynitopoulos, Michael Schneider, Timo Greiner
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMC 2025-06-01
Серии:	Addiction Science & Clinical Practice
Предметы:	Sedatives Hypnotics Anxiolytics Psychotropic drugs Tranquilizing drugs AMSP
Online-ссылка:	https://doi.org/10.1186/s13722-025-00579-6
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!